Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕Zerodha CASE Nifty 50 ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFZerodha CASE Nifty 50 ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaZerodha
NAV₹29.1863₹10.3834
NAV date20 Nov 202620 Nov 2026
History5.4 years1.1 years
Expense ratio0.2%0.1%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFZerodha CASE Nifty 50 ETF
1 month+10.82%+12.78%
3 months+7.43%+6.66%
6 months+14.54%+10.06%
YTD+25.40%−0.06%
1 year+25.57%−0.28%
3 years (CAGR)+22.02%—
5 years (CAGR)+16.60%—
10 years (CAGR)——
Since launch+14.02%+1.00%

Risk

Nippon India Nifty Pharma ETFZerodha CASE Nifty 50 ETF
Volatility15.0%—
Downside volatility9.0%—
Sharpe1.04—
Sortino1.72—
Calmar1.33—
Return / risk1.47—
Deepest fall−20.98%−15.03%
Days to recover136—
Below its high−1.75%−0.82%

Against benchmark

Nippon India Nifty Pharma ETFZerodha CASE Nifty 50 ETF
Alpha+0.00%—
Beta1.00—
R²100.0%—
Up capture100.0%—
Down capture100.0%—
Tracking error0.0%—
Information ratio——
Treynor0.14—

Consistency

Nippon India Nifty Pharma ETFZerodha CASE Nifty 50 ETF
Best 1-year+65.21%−0.28%
Middle 1-year+13.46%−4.19%
Worst 1-year−15.30%−11.66%
1-year periods with a loss25.8%100.0%
Middle 3-year+20.51%—
Positive months61.1%—
Best day+3.64%+3.78%
Worst day−4.03%−3.26%
Worst 5% day−1.62%−1.53%
Positive days54.4%50.0%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFZerodha CASE Nifty 50 ETF
5-year XIRR+20.60%—
5-year value₹10,11,738—
3-year XIRR+19.58%—
1-year XIRR+34.31%+11.41%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth